Sugar reduction and low/no calorie sweeteners in dietary practice
The case of obesity and diabetes
Dear Webinar Attendees,
We are delighted to welcome you to this webinar which is organized by the European Federation of the Associations of Dietitians (EFAD) and two of the ESDNs- Diabetes and Obesity- and made possible through the support of the International Sweeteners Association (ISA). Our aim is to empower dietitians with the knowledge that they need to effectively manage people with obesity and diabetes to reduce their sugar intake based on recommendations. During this webinar, our speakers will share their practical insights and research experience relating to the nutritional status and needs of these patients.
This webinar aims to provide all the latest information and research outcomes on the main characteristics of low/no calorie sweeteners and their role in dietary practice. It will clarify the use of low/no calorie sweeteners in foods and drinks and their role in reformulation and in sugar reduction for people with obesity and diabetes, the effect of low/no calorie sweeteners on reducing energy intake and on weight management, the impact of low/no calorie sweeteners on glucose control and therefore their role in the diet of people with diabetes. The speakers will discuss how low/no calorie sweeteners can be part of a healthy diet and will inform us on sugar reduction policies in Europe through a review of effective strategies. Finally, new data from a network meta-analysis on whether substituting sugar with low/no calorie sweeteners can improve cardiometabolic risk will be presented at the webinar.
We hope you will enjoy this webinar and look forward to seeing primary dietitians and other health care professionals attending the webinar. At the end of this webinar you can expect to have gained the following insight:
- How low/no calorie sweeteners can help meet public health recommendations about sugar intake reduction and if they are linked to a higher-quality diet.
- What the results of the different sugar reduction policies in Europe are.
- What the balance of evidence from human clinical trials shows about if and how low/no calorie sweeteners can aid weight loss and glucose control, when used as a replacement for sugar. Why is there a controversy between observational studies and randomised controlled trials?
- What new evidence shows about the effect of low/no calorie sweeteners on different cardiometabolic risk factors including adiposity, glycaemic control, blood pressure, blood lipid levels, and liver fat.
-
Topics and speakers:
Live Broadcast on 7th October 2020, 19:00-20:00 CET
-
Q&As - Conclusions
With kind regards,
Charilaos Dimosthenopoulos MSc MedSci. SRD. PhDc
Chief Dietitian-Biologist
Dietetic Dept at General Hospital of Athens "Laiko"
Board Member of DNSG & Lead of EFAD European Specialist for Diabetes
Professor Maria Hassapidou,
Department of Nutritional Sciences and Dietetics,
International Hellenic University, Thessaloniki, Greece,
Chair of ESDN Obesity, EFAD
Chair of NWG, EASO
Confirm cancellation
An error occurred trying to play the stream. Please reload the page and try again.
Close
Charilaos Dimosthenopoulos received his BSc in Biological Sciences, in 1993, in 1994 he completed his MMedSci in Human Nutrition at the Sheffield University and in 1996 he received his Postgraduate Diploma in Dietetics, at the Leeds Metropolitan University. He is PhD candidate at the Medical School of the Kapodistriakon University, Athens. He works as Chief Dietitian of the General University Hospital of Athens “Laiko”. He has numerous publications and several abstracts and posters in greek and international congresses. He is member of the committee of the Greek Diabetes Association, Member of the Committee of the Diabetes and Nutrition Study Group of the European Diabetes Association (EASD) and EFAD European Specialist for Diabetes.
Maria Hassapidou is currently Professor of the department of Nutritional Sciences and Dietetics of the International Hellenic University. She is also the coordinator of the post-graduate course on Clinical nutrition and director of the Human Nutrition Laboratory.
She has coordinated and/or participated in several research projects funded by the EU (Health, Diets I and II, Healthgrain, EURRECA, JANPA, BigO, PROTEIN), the Greek Ministries of Health, Education, Research and Technology as well as food and pharmaceutical companies in the areas of dietary assessment and nutritional evaluation, dietary treatment of obese patients with cardio metabolic diseases and childhood obesity.
She is the national coordinator for Greece for COSI (WHO European Childhood Surveillance Initiative), chair of NWG (Nutrition Working Group) of EASO, member of the EASO Childhood Obesity Task Force, member of the board of trustees of EuFoDiN (European Foundation of Dietetics and Nutrition) and chair of the European Specialized Dietetic Network (ESDN) of EFAD on Obesity. She is a member of the Hellenic Nutrition Policy Committee of the Greek Ministry of Health.
She has authored several books and has published more than 100 scientific papers in peer-reviewed journals and conference proceedings in the areas of nutrition and obesity. She is also a reviewer in many related European and International journals.
Maria Hassapidou is currently Professor of the department of Nutritional Sciences and Dietetics of the International Hellenic University. She is also the coordinator of the post-graduate course on Clinical nutrition and director of the Human Nutrition Laboratory.
She has coordinated and/or participated in several research projects funded by the EU (Health, Diets I and II, Healthgrain, EURRECA, JANPA, BigO, PROTEIN), the Greek Ministries of Health, Education, Research and Technology as well as food and pharmaceutical companies in the areas of dietary assessment and nutritional evaluation, dietary treatment of obese patients with cardio metabolic diseases and childhood obesity.
She is the national coordinator for Greece for COSI (WHO European Childhood Surveillance Initiative), chair of NWG (Nutrition Working Group) of EASO, member of the EASO Childhood Obesity Task Force, member of the board of trustees of EuFoDiN (European Foundation of Dietetics and Nutrition) and chair of the European Specialized Dietetic Network (ESDN) of EFAD on Obesity. She is a member of the Hellenic Nutrition Policy Committee of the Greek Ministry of Health.
She has authored several books and has published more than 100 scientific papers in peer-reviewed journals and conference proceedings in the areas of nutrition and obesity. She is also a reviewer in many related European and International journals.
Professor of Public Health Nutrition and Head of Doctoral College at Ulster University, Northern Ireland.
Her research interests resonate within the area of obesity and include the development of risk factors for disease, low-energy/non-nutritive sweeteners and their potential impact on health, physical activity and health (including implementation of lifestyle interventions at key stages across the lifecycle). A Registered Nutritionist (Public Health) and the first Fellow of the Association of Nutrition (FAfN) on the island of Ireland, she is an active member of the UK/Ireland Nutrition Society and was Honorary Programmes Secretary for UK Nutrition Society from 2010-2017 and she co-Chaired the Scientific Committee for the Federation of Nutritional Sciences (FENS) 13th European Nutrition Conference (www.fens2019.org) held in Dublin, 15-18 October 2019. She is co-editor of the Nutrition Society text book Introduction to Human Nutrition (3rd edition). She is a passionate advocate for the European Nutrition Leadership Platform (ENLP), having first participated in the ENLP seminars in 1997 and being involved with this international leadership programme ever since, being the current Chair/President of the ENLP Board and co-Director of the ENLP Essentials seminar (www.enlp.eu.com).
Anne Raben (AR) is Ph.D. in Human Nutrition, Professor in the Obesity Research Unit, and Head of Study Board at the Department of Nutrition, Exercise and Sports (NEXS), SCIENCE, University of Copenhagen, Denmark. AR has solid experience with clinical intervention studies within obesity and related diseases, especially, the role of different macronutrients and carbohydrates – including sugar, non-caloric sweeteners, and glycemic index. Recently, AR was Project Coordinator of a large multinational EU FP7 project “PREVIEW”, Prevention of Diabetes through lifestyle Intervention and populations studies in Europe and around the World (www.previewstudy.com, 2013-18). Currently, AR is co-coordinator of a new Horizon-2020 project “SWEET” focusing on (www.sweetproject.eu, 2018 – 2023) the impact of sweeteners and sweeteners enhancers on health, obesity, safety and sustainability.
Dr. John Sievenpiper, MD, PhD, FRCPC is a Clinician Scientist who holds appointments at the University of Toronto as an Associate Professor in the Department of Nutritional Sciences and the Lifestyle Medicine Lead in the MD Program and at St. Michael’s Hospital as a Staff Physician in the Division of Endocrinology & Metabolism and Scientist in the La Ka Shing Knowledge Institute. Dr. Sievenpiper completed his MSc, PhD and Postdoctoral Fellowship training in the Department of Nutritional Sciences at the University of Toronto. He completed his MD at St. Matthew’s University followed by Residency training in Medical Biochemistry at McMaster University leading to his certification as a Fellow of the Royal College of Physicians of Canada (FRCPC). He has established an internationally recognized research program focused on using randomized controlled trials and systematic reviews and meta-analyses to address questions of clinical and public health importance in relation to diet and cardiometabolic disease prevention with a particular interest in the role of sugars, carbohydrate quality, and plant-based dietary patterns. He is directly involved in knowledge translation with appointments to the nutrition guidelines’ committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada. He is the recipient of numerous awards including a PSI Foundation Graham Farquharson Knowledge Translation Fellowship, Diabetes Canada Clinician Scientist Award, Banting & Best Diabetes Centre Sun Life Financial New Investigator Award, CIHR-INMD/CNS–New Investigator Partnership Prize, and CNS Young Investigator Award. He has authored more than 190 scientific papers and 17 book chapters.